305 related articles for article (PubMed ID: 25476402)
1. Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease.
Napier TC; Corvol JC; Grace AA; Roitman JD; Rowe J; Voon V; Strafella AP
Mov Disord; 2015 Feb; 30(2):141-9. PubMed ID: 25476402
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum of impulse control disorders in Parkinson's disease.
Weintraub D; David AS; Evans AH; Grant JE; Stacy M
Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
[TBL] [Abstract][Full Text] [Related]
3. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.
Leroi I; Barraclough M; McKie S; Hinvest N; Evans J; Elliott R; McDonald K
J Neuropsychol; 2013 Sep; 7(2):306-25. PubMed ID: 23901888
[TBL] [Abstract][Full Text] [Related]
5. Developments in impulse control behaviours of Parkinson's disease.
Zurowski M; O'Brien JD
Curr Opin Neurol; 2015 Aug; 28(4):387-92. PubMed ID: 26110803
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
Krishnamoorthy S; Rajan R; Banerjee M; Kumar H; Sarma G; Krishnan S; Sarma S; Kishore A
Parkinsonism Relat Disord; 2016 Sep; 30():13-7. PubMed ID: 27325396
[TBL] [Abstract][Full Text] [Related]
7. Impulse control disorders in Parkinson's disease: crossroads between neurology, psychiatry and neuroscience.
Bugalho P; Oliveira-Maia AJ
Behav Neurol; 2013 Jan; 27(4):547-57. PubMed ID: 23242359
[TBL] [Abstract][Full Text] [Related]
8. Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity.
Baig F; Kelly MJ; Lawton MA; Ruffmann C; Rolinski M; Klein JC; Barber T; Lo C; Ben-Shlomo Y; Okai D; Hu MT
Neurology; 2019 Aug; 93(7):e675-e687. PubMed ID: 31311842
[TBL] [Abstract][Full Text] [Related]
9. Impulse Control and Related Disorders in Parkinson's Disease.
Weintraub D; Claassen DO
Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
[TBL] [Abstract][Full Text] [Related]
10. The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.
Kon T; Ueno T; Haga R; Tomiyama M
Brain Behav; 2018 Aug; 8(8):e01036. PubMed ID: 29956879
[TBL] [Abstract][Full Text] [Related]
11. Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.
Samuel M; Rodriguez-Oroz M; Antonini A; Brotchie JM; Ray Chaudhuri K; Brown RG; Galpern WR; Nirenberg MJ; Okun MS; Lang AE
Mov Disord; 2015 Feb; 30(2):150-9. PubMed ID: 25607799
[TBL] [Abstract][Full Text] [Related]
12. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
[TBL] [Abstract][Full Text] [Related]
13. Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.
Ramirez-Zamora A; Gee L; Boyd J; Biller J
Expert Rev Neurother; 2016; 16(4):389-99. PubMed ID: 26923084
[TBL] [Abstract][Full Text] [Related]
14. Impulse control disorders in Parkinson's disease.
Weintraub D; Potenza MN
Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
[TBL] [Abstract][Full Text] [Related]
15. Imaging impulse control disorders in Parkinson's disease and their relationship to addiction.
Ray NJ; Strafella AP
J Neural Transm (Vienna); 2013 Apr; 120(4):659-64. PubMed ID: 23232664
[TBL] [Abstract][Full Text] [Related]
16. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
[TBL] [Abstract][Full Text] [Related]
17. A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.
Rizos A; Sauerbier A; Antonini A; Weintraub D; Martinez-Martin P; Kessel B; Henriksen T; Falup-Pecurariu C; Silverdale M; Durner G; Røkenes Karlsen K; Grilo M; Odin P; Chaudhuri KR;
Eur J Neurol; 2016 Aug; 23(8):1255-61. PubMed ID: 27170229
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease.
Staubo SC; Fuskevåg OM; Toft M; Lie IH; Alvik KMJ; Jostad P; Tingvoll SH; Lilleng H; Rosqvist K; Størset E; Odin P; Dietrichs E; Dietrichs ES
Eur J Neurol; 2024 Feb; 31(2):e16144. PubMed ID: 37955562
[TBL] [Abstract][Full Text] [Related]
19. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease.
Jiménez-Urbieta H; Gago B; Quiroga-Varela A; Rodríguez-Chinchilla T; Merino-Galán L; Oregi A; Belloso-Iguerategui A; Delgado-Alvarado M; Navalpotro-Gómez I; Marin C; Fernagut PO; Rodríguez-Oroz MC
Neurobiol Aging; 2019 Mar; 75():126-135. PubMed ID: 30572183
[TBL] [Abstract][Full Text] [Related]
20. Integrating genetic and clinical data to predict impulse control disorders in Parkinson's disease.
Jesús S; Periñán MT; Cortés C; Buiza-Rueda D; Macías-García D; Adarmes A; Muñoz-Delgado L; Labrador-Espinosa MÁ; Tejera-Parrado C; Gómez-Garre MP; Mir P
Eur J Neurol; 2021 Feb; 28(2):459-468. PubMed ID: 33051953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
